Unknown statusInterventionalNot ApplicableUpdated Dec 30, 2016
Gonadotropin-releasing Hormone (GnRH) Downregulation Versus Oral Anticonception Prior to ART in Postoperative Endometriosis Patients | NCT02400801 | Trialant
Gonadotropin-releasing Hormone (GnRH) Downregulation Versus Oral Anticonception Prior to ART in Postoperative Endometriosis Patients
ClinicalTrials.gov ID
NCT02400801
Lead Sponsor
Universitaire Ziekenhuizen KU LeuvenOTHER
Overall Status
Completed
Study Type
Interventional
Phase
Not Applicable
Enrollment
166Estimated
Last Update Posted
Jul 10, 2024Actual
Start Date
Jun 2013Actual
Primary Completion Date
Dec 2017Actual
Completion Date
Jan 26, 2018Actual
Brief Summary
Does prolonged GnRH downregulation prior to ART improve the clinical pregnancy rate in postoperative endometriosis patients? (A single centre randomised controlled trial)
Endometriosis
Infertility
triptorelin
ethinylestradiol + dienogest
Ages Eligible for Study
Adult (18-64)
Sexes Eligible for Study
Female
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
histologically proven endometriosis with complete treatment of all endometriosis lesions during laparoscopy
only first three ART cycles
normal uterine cavity
Eligible for ovarian stimulation with long agonist protocol
Exclusion Criteria:
FSH>20 IU/L
presence of large intramural fibroids (> 3 cm)
<4 oocytes obtained in any previous fresh ART cycle
ART with sperm derived from testicular biopsy
ART with Preimplantation Genetic Diagnosis/Screening